How and where to order Erythromycin 250 mg, 500 mg tablets or capsules online:
|Prices:||from $0.36 per pill
|Discount:||10% coupon: DFHDCC
|Forms:||250 mg, 500 mg tablets or capsules
|Type:||Erythromycin brand and generics
|Payment:||Visa, MasterCard, AmEx, Bitcoin
|Delivery:||Regular and express mail service
|Shipping:||Worldwide, including USA, UK, Europe, Canada, Australia
Erythromycin (trade names include Ilosone, Aknemycin, Akne-Mycin, Apo-Erythro, E-Mycin, Eritromicina GSK, Eromycin, Eryacne, Eryc, Erycin, Eryhexal, Ery-Tab, Erythro CT-Arzneimittel, Erythroforte, Erythromycin Ratiopharm, Erythromycine Bailleul, Erythroped) is a broad-spectrum macrolide antibiotic from macrolides pharmacological group. This medication is used in therapy of many kinds of infections such as respiratory tract, skin, soft tissue, eye, ear, chlamydia infections, some sexually transmitted diseases, dental abscess, pneumonia, legionella pneumonia (Legionnaire's disease), mycoplasma pneumonia, bronchitis, pertussis, pharyngitis, strep throat, pelvic inflammatory disease, nongonococcal urethritis, syphilis, chancroid; Lyme disease, bartonellosis, pemphigoid, bullous pemphigoid, campylobacter gastroenteritis, lymphogranuloma venereum, ocular rosacea, otitis media, for bowel preparation, to prevent "strep" infections in patients with a history of rheumatic heart disease who may be allergic to penicillin; in patients during pregnancy to prevent Group B streptococcal infection in the newborn; for bacterial endocarditis prevention; for prophylaxis of rheumatic fever; to improve delayed stomach emptying; in veterinary medicine. Erythromycin also treats severe acne. The spectrum of responsible bacteria include Corynebacterium minutissimum, Haemophilus influenzae, Staphylococcus aureus, Streptococcus pyogenes. This medicine works by slowing the growth or sometimes killing sensitive bacteria by reducing the production of important proteins needed these bacteria for survive.
Amoxicillin, Clavulanate (Augmentin)
Azelaic Acid (Azelex)
Ofloxacin (Floxin, Ocuflox)
Pharmacological and medical categories:
Acne treatment preparations
Eye anti-infectives and antiseptics
Veterinary, pet meds
D - Dermatologicals
D10 - Anti-acne preparations
D10A - Anti-acne preparations for topical use
D10AF - Antiinfectives for treatment of acne
D10AF02 - Erythromycin
J - Antiinfectives for systemic use
J01 - Antibacterials for systemic use
J01F - Macrolides, lincosamides and streptogramins
J01FA - Macrolides
J01FA01 - Erythromycin
S - Sensory organs
S01 - Ophthalmologicals
S01A - Antiinfectives
S01AA - Antibiotics
S01AA17 - Erythromycin
Other bacterial intestinal infections - A04
Campylobacter enteritis - A04.5
Whooping cough - A37
Bartonellosis - A44
Other bacterial diseases, not elsewhere classified - A48
Bacterial infection of unspecified site - A49
Infections with a predominantly sexual mode of transmission - A50-A64
Early syphilis - A51
Chlamydial lymphogranuloma (venereum) - A55
Chancroid - A57
Legionnaires' disease - A48.1
Infections with a predominantly sexual mode of transmission - A50-A64
Other spirochetal infections - A69
Lyme disease - A69.2
Other diseases caused by chlamydiae - A70-A74
Suppurative and unspecified otitis media - H66
Acute rheumatic fever - I00-I02
Acute and subacute endocarditis - I33
Endocarditis, valve unspecified - I38
Endocarditis and heart valve disorders in diseases classified elsewhere - I39
Acute pharyngitis - J02
Streptococcal pharyngitis - J02.0
Influenza and pneumonia - J09-J18
Bacterial pneumonia, not elsewhere classified - J15
Pneumonia due to Mycoplasma pneumoniae - J15.7
Pneumonia, unspecified organism - J18
Acute bronchitis - J20
Bronchitis, not specified as acute or chronic - J40
Simple and mucopurulent chronic bronchitis - J41
Unspecified chronic bronchitis - J42
Diseases of pulp and periapical tissues - K04
Other diseases of stomach and duodenum - K31
Other specified diseases of stomach and duodenum - K31.8
Gastroparesis - K31.84
Pemphigoid - L12
Bullous pemphigoid - L12.0
Acne - L70
Rosacea - L71
Urethritis and urethral syndrome - N34
Other female pelvic inflammatory diseases - N73
Female pelvic inflammatory disease, unspecified - N73.9
Persons encountering health services for specific procedures and treatment, not carried out - Z53
Indications and usage:
To reduce the development of drug-resistant bacteria and maintain the effectiveness of erythromycin and other antibacterial drugs, erythromycin should be used only to treat or prevent infections that are proven or strongly suspected to be caused by susceptible bacteria. When culture and susceptibility information are available, they should be considered in selecting or modifying antibacterial therapy. In the absence of such data, local epidemiology and susceptibility patterns may contribute to the empiric selection of therapy. Erythromycin tablets are indicated in the treatment of infections caused by susceptible strains of the designated microorganisms in various infective diseases.
Dosage and administration:
In most patients, erythromycin tablets are well absorbed and may be dosed orally without regard to meals. However, optimal blood levels are obtained when either Erythromycin 250 mg or Erythromycin 500 mg tablets are given in the fasting state (at least 1/2 hour and preferably 2 hours before meals).
The usual dosage of erythromycin is one 250 mg tablet every 8 hours or one 500 mg tablet every 12 hours. Dosage may be increased up to 4 g per day according to the severity of the infection. However, twice-a-day dosing is not recommended when doses larger than 1 g daily are administered.
Age, weight, and severity of the infection are important factors in determining the proper dosage. The usual dosage is 30 to 50 mg/kg/day, in equally divided doses. For more severe infections this dosage may be doubled but should not exceed 4 g per day.
In the treatment of streptococcal infections of the upper respiratory tract (e.g., tonsillitis or pharyngitis), the therapeutic dosage of erythromycin should be administered for at least ten days.
The American Heart Association suggests a dosage of 250 mg of erythromycin orally, twice a day in long-term prophylaxis of streptococcal upper respiratory tract infections for the prevention of recurring attacks of rheumatic fever in patients allergic to penicillin and sulfonamides.
Conjunctivitis of the newborn caused by Chlamydia trachomatis
Oral erythromycin suspension 50 mg/kg/day in 4 divided doses for at least 2 weeks.
Pneumonia of infancy caused by Chlamydia trachomatis
Although the optimal duration of therapy has not been established, the recommended therapy is oral erythromycin suspension 50 mg/kg/day in 4 divided doses for at least 3 weeks. Urogenital Infections During Pregnancy Due to Chlamydia trachomatis Although the optimal dose and duration of therapy have not been established, the suggested treatment is 500 mg of erythromycin by mouth four times a day or two erythromycin 250 mg or 333 mg tablets orally every 8 hours on an empty stomach for at least 7 days. For women who cannot tolerate this regimen, a decreased dose of one erythromycin 500 mg tablet orally every 12 hours, one 333 mg tablet orally every 8 hours or 250 mg by mouth four times a day should be used for at least 14 days.
For adults with uncomplicated urethral, endocervical, or rectal infections caused by Chlamydia trachomatis, when tetracycline is contraindicated or not tolerated 500 mg of erythromycin by mouth four times a day or two 333 mg tablets orally every 8 hours for at least 7 days.
For patients with nongonococcal urethritis caused by Ureaplasma urealyticum when tetracycline is contraindicated or not tolerated 500 mg of erythromycin by mouth four times a day or two 333 mg tablets orally every 8 hours for at least seven days.
30 to 40 g given in divided doses over a period of 10 to 15 days.
Acute Pelvic Inflammatory Disease Caused by N. gonorrhoeae
500 mg Erythrocin Lactobionate-I.V. (erythromycin lactobionate for injection, USP) every 6 hours for 3 days, followed by 500 mg of erythromycin base orally every 12 hours, or 333 mg of erythromycin base orally every 8 hours for 7 days.
500 mg every 12 hours, 333 mg every 8 hours or 250 mg every 6 hours for 10 to 14 days.
30 to 50 mg/kg/day in divided doses for 10 to 14 days.
Although optimal dosage and duration have not been established, doses of erythromycin utilized in reported clinical studies were 40 to 50 mg/kg/day, given in divided doses for 5 to 14 days.
Although optimal dosage has not been established, doses utilized in reported clinical data were 1 to 4 g daily in divided doses.
Dosage forms and strengths:
Erythrocin tablets or capsules: 250 mg, 333 mg, 500 mg.
In case of overdosage, erythromycin should be discontinued. Overdosage should be handled with the prompt elimination of unabsorbed drug and all other appropriate measures should be instituted. Erythromycin is not removed by peritoneal dialysis or hemodialysis.
Erythromycin is contraindicated in patients with known hypersensitivity to this antibiotic. This medication is also contraindicated in patients taking terfenadine, astemizole, cisapride, pimozide, ergotamine or dihydroergotamine.
Warnings and precautions:
Hepatotoxicity (patients with impaired hepatic function).
Syphilis in pregnancy.
Clostridium difficile associated diarrhea.
The absence of a proven or strongly suspected bacterial infection or a prophylactic indication.
Side effects, adverse reactions:
The most frequent side effects of oral erythromycin preparations are gastrointestinal and are dose-related. They include nausea, vomiting, abdominal pain, diarrhea and anorexia. Symptoms of hepatitis, hepatic dysfunction and/or abnormal liver function test results may occur.
Onset of pseudomembranous colitis symptoms may occur during or after antibacterial treatment.
Erythromycin has been associated with QT prolongation and ventricular arrhythmias, including ventricular tachycardia and torsades de pointes.
Allergic reactions ranging from urticaria to anaphylaxis have occurred. Skin reactions ranging from mild eruptions to erythema multiforme, Stevens-Johnson syndrome, and toxic epidermal necrolysis have been reported rarely.
There have been reports of interstitial nephritis coincident with erythromycin use.
There have been rare reports of pancreatitis and convulsions.
There have been isolated reports of reversible hearing loss occurring chiefly in patients with renal insufficiency and in patients receiving high doses of erythromycin.
Serious adverse reactions have been reported in patients taking erythromycin concomitantly with CYP3A4 substrates. These include colchicine toxicity with colchicine; rhabdomyolysis with simvastatin, lovastatin, and atorvastatin; and hypotension with calcium channel blockers metabolized by CYP3A4 (e.g., verapamil, amlodipine, diltiazem).
There have been post-marketing reports of colchicine toxicity with concomitant use of erythromycin and colchicine. This interaction is potentially life-threatening, and may occur while using both drugs at their recommended doses.
Rhabdomyolysis with or without renal impairment has been reported in seriously ill patients receiving erythromycin concomitantly with lovastatin. Therefore, patients receiving concomitant lovastatin and erythromycin should be carefully monitored for creatine kinase (CK) and serum transaminase levels.
Information for patients:
Patients should be counseled that antibacterial drugs including erythromycin should only be used to treat bacterial infections. They do not treat viral infections (e.g., the common cold). When erythromycin is prescribed to treat a bacterial infection, patients should be told that although it is common to feel better early in the course of therapy, the medication should be taken exactly as directed. Skipping doses or not completing the full course of therapy may decrease the effectiveness of the immediate treatment and increase the likelihood that bacteria will develop resistance and will not be treatable by PCE or other antibacterial drugs in the future.
Diarrhea is a common problem caused by antibiotics which usually ends when the antibiotic is discontinued. Sometimes after starting treatment with antibiotics, patients can develop watery and bloody stools (with or without stomach cramps and fever) even as late as two or more months after having taken the last dose of the antibiotic. If this occurs, patients should contact their physician as soon as possible.
A - Australia
B - United States (No evidence of risk in humans)
Salts and other forms:
Erythromycin Stearate Laurilsulfate
Erythromycin Thiocyanate Escine
Synonyms, international and chemical names:
Brands, generics, trade names:
Abboticin - Abbott
Acnederm - Pfizer
Acneryne - Galderma
Aknefug-EL - Dr. August Wolff Arzneimittel
Aknemycin - Boots, Hermal Kurt Herrmann
Akne-Mycin - Boots
Apo-Erythro - Apotex
Deripil - Galderma
E.E.S. - Abbott, Amdipharm, Arbor Pharmaceuticals, Pfizer, Zuellig Pharma
E-Mycin - Pfizer, Abbott, Alphapharm, Pacific Pharmaceuticals, Perrigo
Eritrocina - Abbott
Eritromed - Biocumed Laboratorio
Eritromicina - GlaxoSmithKline, Sanofi-Aventis
Eritrofarm - ICN Pharmaceuticals
Eromycin - Eli Lilly, Gulf Pharmaceutical Industries, Julphar
Ery - Recordati, Interdelta, Tedis
Ery-Max - AstraZeneca, Schwarz Pharma
Eryacne - Galderma, Emcure Pharmaceuticals, Lavipharm Group, Pacific Pharmaceuticals, Summit, U.S. Summit, Zuellig Pharma
Eryacnen - Galderma
Eryaknen - Galderma, AB-Consult Handels
Eryc - Pfizer, Faulding, Hospira, Mayne Pharma, Taro Pharmaceutical Industries, Teva, Warner Chilcott
Erycin - Cipla
Eryderm - Abbott, Zuellig Pharma
Eryfluid - Pierre Fabre
Eryhexal - Hexal
Eryped - Abbott, Arbor Pharmaceuticals
Ery-Tab - Abbott
Erythro - CT-Arzneimittel, Drug Houses of Australia
Erythro-Base - AA Pharma, Pro Doc
Erythroforte - Abbott
Erythromycin - Abbott, Merck, Nycomed, Pro Doc, Ratiopharm, Sandoz, Stada, Teva
Erythromycine - Bailleul Laboratoires, Merck, Mylan, Sterigen Laboratoires
Erythroped - Abbott
Erythrotrop - Teva
Gallimycin - Vetoquinol, A.P.A.
Ilosone - Eli Lilly
Iloticina - Eli Lilly, Derly, Medac Farmaceutica
Ilotycin - Eli Lilly, Aspen Pharmacare, Dista
Inderm - Sankyo, Dermapharm, Will-Pharma
InfectoMycin - Infectopharm Arzneimittel und Consilium
Loderm - Vinas
Oftalmolosa Cusi Erythromycin - Alcon, Summit
Sansacne - Galderma, Metro Drug Distribution
Stiemycin - Stiefel Laboratories, Allphar Services, Bipharma, David Sparks, Firma Popular, Zuellig Pharma
APIs used in medicine in combinations with erythromycin:
Here is a list of popular medications containing erythromycin as a main active pharmaceutical ingredient; their trade names, forms, doses, companies - manufacturers, distributors, suppliers, researchers and developers:
|Trade name of the drug
||Pharmaceutical forms and doses
||Cream; Topical; Erythromycin 2%Gel; Topical; Erythromycin 2%Ointment; Topical; Erythromycin 2%Solution; Topical; Erythromycin 2%
||BootsAlmirallDow Pharmaceutical SciencesHealthpointHermal Kurt HerrmanniNova PharmaceuticalsValeant PharmaceuticalsZuellig Pharma
||Tablets, Delayed Release; Oral; Erythromycin 250 mgTablets, Delayed Release; Oral; Erythromycin 333 mgTablets, Delayed Release; Oral; Erythromycin 500 mg
||Capsules; Oral; Erythromycin Estolate 125 mgCapsules; Oral; Erythromycin Estolate 250 mgDrops; Oral; Erythromycin Estolate 100 mg / mlPowder for Suspension; Oral; Erythromycin Estolate 125 mg / 5 mlSuspension; Oral; Erythromycin Estolate 100 mg / mlSuspension; Oral; Erythromycin Estolate 125 mg / 5 mlSuspension; Oral; Erythromycin Estolate 250 mg / 5 mlSyrup; Oral; Erythromycin Estolate 125 mg / 5 mlSyrup; Oral; Erythromycin Estolate 250 mg / 5 mlTablets, Chewable; Oral; Erythromycin Estolate 125 mgTablets, Chewable; Oral; Erythromycin Estolate 250 mgTablets; Oral; Erythromycin Estolate 500 mg
||Eli LillyAspenCipa LaboratorioDiethelmDistaDKSHGlaxoSmithKlineICN PharmaceuticalsMore Pharma CorporationValeant PharmaceuticalsYungjin PharmaceuticalZuellig Pharma
Erythromycin main article on Wikipedia: https://en.wikipedia.org/wiki/Erythromycin
Erythromycin compound on PubChem: https://pubchem.ncbi.nlm.nih.gov/compound/Erythromycin
Erythromycin Acistrate compound on PubChem: https://pubchem.ncbi.nlm.nih.gov/compound/Erythromycin-acistrate
Erythromycin Dihydrate compound on PubChem: https://pubchem.ncbi.nlm.nih.gov/compound/Erythromycin-dihydrate
Erythromycin Estolate compound on PubChem: https://pubchem.ncbi.nlm.nih.gov/compound/Erythromycin-estolate
Erythromycin Ethylcarbonate compound on PubChem: https://pubchem.ncbi.nlm.nih.gov/compound/Erythromycin-ethylcarbonate
Erythromycin Ethylsuccinate compound on PubChem: https://pubchem.ncbi.nlm.nih.gov/compound/Erythromycin-ethyl-succinate
Erythromycin Gluceptate compound on PubChem: https://pubchem.ncbi.nlm.nih.gov/compound/Erythromycin-gluceptate
Erythromycin Lactobionate compound on PubChem: https://pubchem.ncbi.nlm.nih.gov/compound/Erythromycin-lactobionate
Erythromycin Phosphate compound on PubChem: https://pubchem.ncbi.nlm.nih.gov/compound/Erythromycin-phosphate
Erythromycin Propionate compound on PubChem: https://pubchem.ncbi.nlm.nih.gov/compound/Erythromycin-propionate
Erythromycin Stearate compound on PubChem: https://pubchem.ncbi.nlm.nih.gov/compound/Erythromycin-stearate
Erythromycin Stinoprate compound on PubChem: https://pubchem.ncbi.nlm.nih.gov/compound/Erythromycin-stinoprate
Erythromycin Thiocyanate compound on PubChem: https://pubchem.ncbi.nlm.nih.gov/compound/Erythromycin-thiocyanate
Erythromycin on DrugBank: https://www.drugbank.ca/drugs/DB00199
Erythromycin Estolate on DrugBank: https://www.drugbank.ca/salts/DBSALT001358
Erythromycin Ethylsuccinate on DrugBank: https://www.drugbank.ca/salts/DBSALT001220
Erythromycin Gluceptate on DrugBank: https://www.drugbank.ca/salts/DBSALT001340
Erythromycin Lactobionate on DrugBank: https://www.drugbank.ca/salts/DBSALT001219
Erythromycin Phosphate on DrugBank: https://www.drugbank.ca/salts/DBSALT001624
Erythromycin Stearate on DrugBank: https://www.drugbank.ca/salts/DBSALT001221
Erythromycin Thiocyanate on DrugBank: https://www.drugbank.ca/salts/DBSALT001625
Erythromycin FAQ on MedlinePlus (revised 09/15/2019): https://medlineplus.gov/druginfo/meds/a682381.html
Erythromycin Ophthalmic FAQ on MedlinePlus (revised 01/15/2017): https://medlineplus.gov/druginfo/meds/a613018.html
Erythromycin film-coated tablets drug label info on DailyMed (revised March 3, 2011): https://dailymed.nlm.nih.gov/dailymed/drugInfo...
Ery-Tab (Erythromycin) delayed-release tablets drug label info on DailyMed (revised December 4, 2018): https://dailymed.nlm.nih.gov/dailymed/lookup...
Ery-Ped (Erythromycin Ethylsuccinate) suspension drug label info on DailyMed (revised January 24, 2020): https://dailymed.nlm.nih.gov/dailymed/lookup...
Erythromycin containing drugs on Drugs-About.com: https://drugs-about.com/ing/erythromycin.html
Erythromycin for sale on Pharma Doctor: https://pharma-doctor.com/erythromycin.html
Erythromycin international drug names on Drugs.com: https://www.drugs.com/international/erythromycin.html
E.E.S. and Ery-Ped (Erythromycin Ethylsuccinate) film-coated tablets and powder for oral suspension official prescribing information from the U.S. FDA (revised January 2012): https://www.accessdata.fda.gov/drugsatfda_docs/label...
PCE (Erythromycin) tablets official prescribing information from the U.S. FDA (revised 11/2010): https://www.accessdata.fda.gov/drugsatfda_docs/label...
Erythrocin (Erythromycin) 250 mg and 500 mg tablets package information leaflet on Medicines.org.uk (revised December 2017): https://www.medicines.org.uk/emc/files/pil.404.pdf
Erythromycin Amdipharm 250 mg tablets package information leaflet on HPRA (revised July 2017): https://www.hpra.ie/img/uploaded/swedocuments...
Revised: April 2021
Home | Physicians | Patient Info | Articles | Laser Aesthetics | Locations
Copyright © 2005 - 2021 CircleMed HealthCare. All rights reserved.